Clinical Trial Update: Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension [Phase 2]

View source ↗

Summary

The document reports Phase 2 trial results on Terbogrel for primary pulmonary hypertension, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Terbogrel (terbogrel)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Pulmonary | Phase 2 | Status: COMPLETED